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The temperate coliphage , after infecting its host bacterium
Escherichia coli, can develop either along the lytic or the lysogenic
pathway. Crucial to the lysislysogeny decision is the homotet-
rameric transcription-activator protein CII (4 11 kDa) of the phage
that binds to a unique direct-repeat sequence T-T-G-C-N6-T-T-G-C at
each of the three phage promoters it activates: pE, pI, and paQ.
Several regions of CII have been identified for its various functions
(DNA binding, oligomerization, and susceptibility to host pro-
tease), but the crystal structure of the protein long remained
elusive. Here, we present the three-dimensional structure of CII at
2.6-Å resolution. The CII monomer is comprised of four  helices
and a disordered C terminus. The first three helices (1–3) form a
compact domain, whereas the fourth helix (4) protrudes in
different orientations in each subunit. A four-helix bundle, formed
by 4 from each subunit, holds the tetramer. The quaternary
structure can be described as a dimer of dimers, but the tetramer
does not exhibit a closed symmetry. This unusual quaternary
arrangement allows the placement of the helix–turn–helix motifs
of two of the four CII subunits for interaction with successive major
grooves of B-DNA, from one face of DNA. This structure provides
a simple explanation for how a homotetrameric protein may
recognize a direct-repeat DNA sequence rather than the inverted-
repeat sequences of most prokaryotic activators.
direct-repeat recognition  helix–turn–helix motif  transcription activator
The CII protein of phage  is a transcription activator that hasattracted the attention of researchers for diverse reasons. On
one hand, CII is a key regulator for the temperate coliphage,
enabling the virus to make the choice between the lytic and
lysogenic pathways of development (1). On the other hand, CII
is the only known example of a DNA-binding protein that
recognizes direct-repeat sequences in DNA (2) rather than the
commonly observed inverted-repeat sequences in most prokary-
otic transcription activators (3).
After infecting its host bacterium Escherichia coli,  can follow
either of its two alternate modes of development, namely, lytic or
lysogenic. The choice between these pathways is an important
decision in the life cycle of the phage (1, 4) and is influenced by
factors such as temperature, nutrient concentration, and multiplic-
ity of infection. In fact, this decision-making process was one of the
early paradigms for studying gene control and the understanding of
molecular switches (5). The phage has developed an intricate
molecular machinery for this purpose, involving several proteins
from both the phage and the bacterial host (1). Lysogenic devel-
opment requires the synthesis of  CI repressor, for which CII is
absolutely essential. CII coordinately activates transcription from
the three phage promoters pE (required for initial synthesis of
repressor CI), pI (necessary for synthesizing the integrase protein),
and paQ (directs the synthesis of an antisense RNA to reduce late
gene expression), all of which drive the virus toward lysogeny. A
striking feature common to all these promoters is the recognition
site for CII, a 14-bp direct-repeat sequence T-T-G-C-N6-T-T-G-C.
It has been shown that the four terminal repeat sequences TTGC
are essential for CII activity (6, 7). Indeed, CII contacts DNA at the
TTGC tetrads (2). Thus, CII represents a unique example of a
DNA-binding protein that recognizes direct-repeat, rather than
inverted-repeat sequences, as found for most prokaryotic transcrip-
tion activators (3). Nevertheless, like in other activators (3), it is a
helix-turn-helix (HTH) motif that is, presumably, used by CII for
DNA recognition (8). The recognition sequence ofCII implies that,
to contact the TTGC sequences that are positioned 10 bp apart, CII
must interact with DNA on one face. How CII achieves this has
remained a mystery. The protein could not be crystallized until
recently (9), despite its successful purification decades ago (10).
In this article, we report the three-dimensional structure of
tetrameric CII at 2.6-Å resolution. It is known that CII exists as a
homotetramer in the native state (10), and the tetrameric organi-
zation is necessary for its activity and for DNA binding (11). Our
crystal structure displays a surprising and unprecedented mode of
oligomer formation that makes it possible to explain how the
tetrameric molecule may bind to a direct-repeat sequence, as found
in the cognate DNA-binding sites of CII. Many biochemical and
mutational data on CII are also explained by this structure.
Methods
Protein Expression and Purification. CII was overexpressed and
purified from an E. coli BL21(DE3) strain transformed with the
recombinant plasmid pAB305 according to the protocol described
in ref. 9. In short, the protein was overexpressed with the addition
of 100 M isopropyl -D-thiogalactoside at 37°C to culture at
midlog phase for 3 h. Harvested cells were lysed by sonication, and
the protein in the soluble phasewas purified by 40–55%ammonium
sulfate precipitation, followed by two consecutive steps of ion-
exchange chromatography using the SP-Sepharose FF (Amersham
Pharmacia Biosciences) and High-S (Bio-Rad) columns. The pu-
rified protein was dialyzed against 20 mMTrisHCl (pH 8.0), 1 mM
EDTA, and 300 mM NaCl and concentrated to 7 mgml. Sel-
enomethionyl derivative was prepared by expressing the protein in
met E. coli strain B834(DE3) in the modified M9 media (12),
containing selenomethionine at a concentration of 4 mgml. The
purification protocol was identical to that for the native protein,
except for the inclusion of 5 mM -mercaptoethanol to all of the
buffers to prevent the unwanted oxidation of selenomethionyl
residues.
Crystallization. Crystals of CII were obtained in hanging drops at
25°C by mixing 2 l of protein solution and 1 l of a precipitant
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solution, containing 17% (wtvol) polyethylene glycol (PEG 3350)
and 8% (volvol) isopropanol. The crystals typically grew in 7–12
days to a maximum size of 0.5 mm and diffracted x-rays typically,
to 3.2-Å resolution.
Data Collection. Diffraction data sets were collected at 100 K from
crystals flash-frozen in liquid nitrogen after soaking them in
cryoprotectant solution containing 17.5% (volvol) glycerol. The
multiple-wavelength anomalous dispersion (MAD) data sets were
collected at the selenium edge at the beamline BW7A of the
EuropeanMolecular Biology Laboratory (EMBL). The native data
set was collected at the fixed-wavelength beamline X13 of EMBL.
All data sets were processed by using the programs DENZO and
SCALEPACK (13). Table 1 shows the statistics of the data sets used
for phasing and structure solution.
Structure Determination and Refinement. FA values to 4.0 Å, ob-
tained by using the program XPREP (Bruker-AXS, Karlsruhe,
Germany) for the selenomethionyl-containing crystal, were used to
solve the selenium substructure (12 of 20 seleniums) with the
program SHELXD (14). Phases were obtained to 4.0 Å by a four-
wavelengthMAD experiment. The phases were extended to 3.04 Å
by using the program DM (15) in the CCP4 suite of programs (16).
The map was of excellent quality. In each monomer, 58 of 97
residues could be built automatically by using the programRESOLVE
(17). Once the orientation of the four monomers was known,
noncrystallographic symmetry (NCS) operators for each monomer
with respect to the first monomer were calculated and then sub-
jected for a second round of density modification in DM for NCS
averaging and phase extension to 2.6 Å. The resulting map allowed
the building of the loop regions and a number of side chains in each
monomer. When there was no further interpretable density in the
experiment map, the model was subjected to refinement by using
the program CNS (18). The final model contains 320 amino acid
residues and exhibits an R factor of 24% (Rfree 28%) (for details,
Table 1. Data collection, phasing, and refinement statistics
Data collection and phasing
Selenomethionyl
NativePeak Inflection point Low-energy remote High-energy remote
No. of crystals 1 1
Total rotation range, ° 110 110 110 180 180
Wavelength, Å 0.9836 0.9841 0.9949 0.9733 0.8013
Space group C2221
Cell dimensions (a, b, c), Å 64.25, 107.79, 121.01 63.91, 106.79, 119.78
Resolution range, Å 32.57–3.04 (3.09–3.04) 20.0–2.55 (2.59–2.55)
Mosaicity, ° 0.46 0.44 0.45 0.44 0.56
Measured reflections 70,959 71,573 71,395 71,307 88,801
Unique reflections 8,391 8,391 8,385 8,388 13,650
Average redundancy 8.5 8.5 8.5 8.5 6.5
I(I)* 9.9 (1.2) 8.7 (1.5) 12.0 (1.4) 12.1 (1.5) 22.4 (2.1)
Completeness, %* 99.9 (100.0) 99.9 (100.0) 99.9 (100.0) 99.9 (100.0) 99.8 (99.4)
Rmerge, %*† 9.5 (68.7) 7.1 (51.8) 6.3 (51.8) 7.6 (50.3) 6.8 (71.9)
Rrim, %*‡ 10.1 (73.1) 7.6 (55.1) 6.8 (55.1) 8.1 (53.5) 7.5 (78.6)
Rpim, %*§ 3.4 (24.7) 2.6 (18.5) 2.3 (18.6) 2.7 (18.0) 2.9 (31.3)
Ranom, %*¶ 6.3 (19.2) 4.0 (17.0) 2.2 (17.5) 4.9 (16.3) ND
Overall B factor, Å2 85.5 84.6 87.6 85.8 77.2
Phasing power (acentric) 1.58 0 2.18 2.3 —
Rcullis (acentric)** 0.68 1.00 0.59 0.57 —
Rcullis (anomalous)** 0.70 0.76 0.97 0.74 —
Refinement
Resolution limits, Å 20.0–2.56
Data cutoff, F (F) 0.0
Total no. of reflections 13,502
Reflections in working set 12,552
Reflections in test set 950
R-factor, %†† 24.6
Rfree, %‡‡ 28.6
No. of protein atoms§§ 2,440
No. of solvent atoms§§ 42
No. of i-propanol atoms§§ 8
R.m.s. bond lengths, Å 0.009
R.m.s. bond angles, ° 1.3
Ramachandran plot (most-favored), % 90.5
ND, not determined.
*Values in parentheses are for the highest resolution shell.
†Rmerge  [hkl i Ii(hkl)  I(hkl)hkl i Ii(hkl)], where Ii(hkl) is the ith measurement of reflection hkl and I(hkl) its average.
‡Rrim  hkl[N(N-1)]12 i Ii(hkl)  I(hkl)hkl i Ii(hkl) (58).
§Rpim  hkl[1(N-1)]12 i Ii(hkl)  I(hkl)hkl i Ii(hkl) (58).
¶Ranom  [hkl I(hkl)  I(h k l)hkl 0.5 I(hkl)  I(h k l)].
Phasing power  rms (FHE), where E is the residual lack of closure.
**Rcullis  FPH,O  FP,O  FH,C FPH,O  FP,O.
††Rfactor  [hklFobs  k Fcalc hklFobs], where Fobs and Fcalc are the observed and calculated structure factor amplitudes, respectively.
‡‡Rfree, same for a test set of reflections not used during refinement.
§§per asymmetric unit.
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see Table 1). In all four monomers, 17 C-terminal residues are
disordered. In the Ramachandran plot, 90.5% and 9.5% of all
residues are in the most-favored and allowed regions, respectively.
The coordinates and structure factors have been deposited in the
Protein Data Bank under the accession code 1XWR.
Before collection of the data sets mentioned above, two data sets
were also collected at the beamline BL40B2 of SPring-8 (data
statistics not shown) (19) to 3.2-Å resolution around the Se edge.
Se sites could be located also from the peak data set. However,
phasing using either single-wavelength anomalous dispersion
(SAD) or the two-wavelength MAD protocol was poor, and, after
solvent flattening, the quality of electron density was not sufficient
to build the model completely. The poor phasing could be a
consequence of radiation damage.
Results and Discussion
Full-length CII crystallizes in the space group C2221, with four
molecules in the asymmetric unit (9). Phases were estimated
from a MAD experiment on selenomethionine-substituted CII
with data extending to 3.04 Å, and the structure was refined
against a native data set extending to 2.6 Å (Table 1). A typical
section of the electron density map near the dimeric interface
AB (see below) is displayed in Fig. 1.
Overall Architecture. The structure of CII tetramer is shown in Fig.
2A. It is an all-helix structure in which the four monomers A–D
associate via a four-helix bundle near the center of the molecule.
The four monomers can be thought of as two pairs (AB and CD).
Members of each pair have stronger association between them,
compared with that between the pairs. Several aspects of the
structure are noteworthy. First, not all of the residues are seen: A
significant part of the C terminus is absent in each subunit. Second,
the individual monomers are held together in the tetramer pre-
dominantly by the C-terminal helix (4) from each monomer. The
orientation of this helix is different in each subunit. Finally, the
quaternary structure lacks a closed point group symmetry, an
unusual feature for a homotetramer.
A subunit of CII consists of four -helices, 1–4, of which the
first three form a compact domain (one such subunit is shown in
Fig. 2B), with the fourth protruding away. Only residues 2–80 were
visible in the electron density map: The first (N-terminal) residue
and 17 residues (this number differs slightly among different
subunits) at the C terminus in the polypeptide chain could not be
located. This finding indicates a disordered C terminus, as expected
from our previous data (20). This flexible C terminus has been
found to act as a target for rapid proteolysis by the protease HflB
(21) and plays an important role in the lysislysogeny decision by
makingCII unstable in vivo (22).Helices2 and3 contain residues
26–45, the proposed HTH motif (8) characteristic of prokaryotic
regulatory proteins (3, 23). This region of CII has been implicated
in DNA-binding frommutational studies (24). The 21-residue helix
3 is longer than the typical second helix in the HTH motif.
However, there is actually a break in the helix in subunit C, with the
residues Lys-44 to Asp-46 being in a nonhelical conformation.
Moreover, the classical HTH motif has a 3-residue long turn,
although longer loop regions are also known (25). InCII, this region
is 6 residues long. The interhelical angle of 90° is typical.
A search against other known folds using the program DALI (26)
did not reveal any structural alignment with any other chain of
similar length. However, the overall trace of the chain distantly
resembles (Z-score 3.3, rms deviation 4.7 Å over 52 residues)
the 116-residue FlhD (27), which is also a transcriptional activator
(of flagellar genes in E. coli). In association with FlhC, FlhD acts
as a heterotetramer. FlhD itself is dimeric, and the monomer is
predominantly -helical. It is noteworthy that, akin to CII, the
N-terminal helix is the longest in the FlhD structure, and the 34
C-terminal residues that protrude from the more compact N-
terminal region are mostly disordered.
Structures of CII Monomers in the Tetramer. The most surprising
aspect of CII structure is that, although CII is a homotetramer, the
orientation of the -helix 4 (4) relative to the compact N-terminal
domain is different in each of the four subunits (Fig. 2C). This
conformational plasticity resides in the peptide fragment Glu-59-
Trp-60-Gly-61-Val-62-Val-63 between helices 3 and 4. It may be
noted that an aromatic residue followed by Gly in this region is
conserved among many homologous sequences (11).
Other examples are known of the same amino acid sequence
forming two different structures, resulting in an asymmetric subunit
interaction. These include the HIV type 1 reverse transcriptase
(28), the two-domain transcription regulator cAMP receptor pro-
tein from E. coli (29), and the LysR-type transcriptional regulator
CbnR (30). The latter is a tetrameric structure that can be regarded
as a dimer of dimers, where the two subunits in each dimer exist in
different conformations, orienting the regulatory domains differ-
ently with respect to the linker helix. However, in all three cases, the
polypeptide chain has multiple domains with different relative
orientations. In contrast, CII is unique because it is a small,
single-domain protein, with each of the four chains having a
different orientation of the 4 helix relative to the rest of the
structure, brought about by conformational flexibility in a short
linker region.
Oligomeric Structure and Quaternary Interactions. Homotetrameric
proteins generally have the point group symmetry 222 (31). How-
ever, the quaternary structure of CII (Fig. 2A) does not exhibit any
closed point group symmetry. The symmetry axes relating the
individual subunits (N-terminal region, residues 7–58) and their
pairs are shown in Fig. 2D. The individual monomers in the subunit
pairs AB and CD are related by twofold axes, implying that the
same set of residues in all subunits is involved in dimeric interactions
across the interface. A small part of the dimeric interface in AB can
be seen in Fig. 1. The two twofold axes in the dimers are not normal
to each other as found in most cases, but are inclined at an angle
of 28°.Moreover, the dimer CD is related to the dimerAB by a 179°
rotation coupledwith a translation of 19.3Å. Such a local screw axis
is also known to relate monomers in the hexokinase dimer (32).
TheCII tetramer is held together by interactions between the two
nearly equivalent dimers AB and CD. The pairwise interface area
Fig. 1. A section of the 2F0  FC map contoured at 1, showing the
interaction between two Phe rings (belonging to the A and B subunits) across
the dimeric interface.
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buried between the two subunits of these dimers is about the same
(2,697 Å2 and 2,619 Å2) (Table 2) and is in the same range as that
observed for other homodimeric proteins (33, 36). Compared with
AB or CD, other subunit pairs (e.g., AC) have a much smaller
buried surface. In the AB pair, 68 residues from the two chains
constitute the interface, with helices 3 and 4 contributing the
most. Among the parameters used to characterize the interfaces
(37), the fraction of interface atoms that are completely buried
(34%) is comparable to those found in other dimers. However, the
number (two) of hydrogen bonds between the chains is lower and
the fraction of nonpolar interface area (77%) is higher than the
average values (18% and 65%, respectively), indicating that hydro-
phobic interaction plays a dominant role in holding the CII dimer
tightly.
The dimer–dimer interface formed between AB and CD has an
area of 1,692 Å2, about 60% of the area buried between individual
monomers within a dimer. Residues in the 4 helix provide most of
the tetrameric contacts, also apparent from the data given in Table
2. For example, the subunits B and D lining the molecular local
screw axis bury 895 Å2 between them, of which 484 Å2 (i.e., 54%)
is accounted for by 4. The importance of 4 (which encompasses
residues 64–79) in tetramer formation is expected from our recent
data (11), where residues 69–81 were implicated in tetramer
formation. Four such helices, one from each subunit of CII,
associate to form a four-helix bundle near the center of the
molecule (Fig. 2A). According to the taxonomy of four-helix-
bundle motifs in globular proteins (38), CII corresponds to the type
X. This pattern of helix packing is important in the structural
organization of several other oligomeric proteins, including two
other transcription factors, namely, the tumor-suppressor protein
p53 (39) and lac repressor (LacI) (40). In the latter, the C-terminal
helix (residues 340–357) from each subunit protrudes from the C
subdomain and participates in interactions that hold the tetramer,
very similar to what we observe in CII. For LacI, deletion of this
helix results in a dimeric version that binds a single operator with
virtually the same affinity as the tetramer (41). Purine repressor
(PurR), another member of the LacI family, lacks the C-terminal
Fig. 2. Structure of the coliphage  transcription activator protein CII. (A) Ribbon representation of the homotetrameric structure. The individual subunits are
differently colored and are indicated by letters (A–D). (B) Ribbon representation of the structure of one subunit (A chain) of CII. The -helices and their ranges
are marked. The HTH motif is shown in blue, and the flexible loop between 3 and 4 is shown in green. This part has different conformations in the different
subunits. (C) Superposition of the N-terminal compact domains (1–3) of the four subunits (A–D), showing the different orientations of the C-terminal helix
4. (D) The local dyads (in cyan within dimers and magenta between dimers) relating the N-terminal domains of the four subunits (A–D). The angular disposition
between the two dimeric axes and the rotational and translational components of the screw axis relating the dimers are shown in the box.
Table 2. Interface areas (Å2) buried between different pairs of
CII subunits
Subunit IDs B C D
A 2,697 (661, 0.24) 400 (400, 1.00) 514 (462, 0.90)
B 196 (196, 1.00) 895 (484, 0.54)
C 2,619 (526, 0.20)
The interface area, 	ASA, represents the surface of the two chains buried
when they are brought in contact; it is the sum of the solvent-accessible
surface areas (ASA) of the individual subunits minus the ASA of the assembly
of the two taken together (33). ASA was calculated by using the program
NACCESS (34), which implements the algorithm of Lee and Richards (35). The
interface area contributed by the residues in the interacting helices (4) from
the two chains is given in parentheses (the first value denotes area in Å2, the
second denotes the fraction of the total interface area that is contributed
by 4).
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helix and is active as a dimer (42). In comparison, the 4 helices of
CII that contribute to most of the tetrameric interactions are
indispensable for bothDNAbinding and the activity of CII (11, 21).
Although dimeric mutants of CII have not been found, deletion of
the 4 region leads to the formation of dimeric CII in vitro (11).
These truncated CII molecules, despite retaining the residues
important for DNA binding, fail to bind DNA. Thus, tetramer
formation is a prerequisite for CII activity.
Another common structural aspect emerges when CII is com-
paredwith other homotetramericDNA-binding proteins. Although
the symmetry relating the two dimers in the tetrameric structure is
different, CII, lac repressor (40), and CbnR (30) are all roughly
V-shaped molecules, with the DNA-binding motifs located on top.
Comparison with Mutational Data. A large number of CII mutants
have been studied (2, 24). These data have identified residues in CII
that are important for tetramer formation or for DNA binding.
Elucidation of the crystal structure enables us to compare these
data with our structure. Such a comparison is shown in Fig. 3, where
the residues involved in dimer contacts (i.e., betweenmonomers) or
between tetramer contacts (between the two dimers) are marked.
There is also a set of residues that participate in both dimeric and
tetrameric contacts, and these are also indicated separately. A
mapping of the reported mutations that affect oligomerization or
DNA binding on this schematic diagram shows that (i) most
mutations that affect oligomer formation are, indeed, located on an
interface region (dimertetramerboth); the only exceptions are
mutations at Ala-10 and Leu-11 that belong to the 1 helix, and (ii)
mutations that affect DNA binding are located exclusively within
theHTHmotif formed by 2–3. This region of the protein is most
likely to be involved in DNA recognition, as discussed below.
Significantly, mutations that lead to the loss of oligomerization also
lead to the loss of activity. Furthermore, no dimeric mutant of CII
has been found: Mutations that affect oligomerization invariably
give rise to monomeric CII. This finding can be explained from our
structure, because most of these mutations are located in the
dimeric (or both dimeric and tetrameric) interfaces (here, again, we
have exceptions in the form of mutations at Ser-15, Asn-19, and
Gly-25 that are involved exclusively in tetramer contacts and not in
dimeric contacts).
Direct-Repeat Recognition. Recognition of the direct-repeat se-
quence T-T-G-C-N6-T-T-G-C and binding to the same strand of
DNA distinguishes CII from other prokaryotic transcription acti-
vators. This sequence is conserved in the 35 region of the three
 promoters that CII activates. Presumably, other CII or CII-like
proteins from lambdoid phages also have a closely similar sequence
for CII binding. It has been shown that the change of one base in
either of the tetrad repeats, although resulting in reduced CII
binding and impaired lysogenicity, may be tolerated (43). The C1
protein of P22 (which is analogous to  CII) recognizes the
T-T-G-C-N6-T-T-G-T sequence present in pE of P22 (44, 45).What
makes CII recognize such direct repeats? The x-ray structure
presented here offers an explanation for this unusual property of
the protein. In the absence of the structure of CII-DNA cocrystal,
we constructed a model for CII-DNA interaction by juxtaposition
of our CII structure to a B-DNA model (shown in Fig. 4).
Placement of the HTH motif of subunit A into the major groove
brings the HTH of subunit D very close to the next major groove,
with the same DNA strand interacting with the two motifs. This is
the only way that two HTH motifs of the protein may contact
successive major grooves in B-DNA. The A and D subunits of CII
are related by a 38-Å translation and a 28° rotation. This relation-
ship means that the same set of residues from the two subunits are
likely to interact with equivalent positions in DNA, 10 bp apart and
in the same strand (ideally, this would require a translation of 34 Å
and a rotation of 0°). Some distortion of the protein (or DNA)
would be required for simultaneous major-groove binding by the
two HTH motifs that may be accommodated by conformational
changes in the DNA, or in the protein, or in both. The structure of
CII, apart from this mismatch of distance (and orientation) of the
twoHTHmotifs, is ideally suited for bindingB-DNA from the same
face and at successive major grooves, implying recognition of a
direct-repeat sequence with a repeat distance of 10 bp, as found in
CII-binding sequences.
We note that the recognition helices of the HTH motifs from
only the A and D subunits can fit into successive major grooves of
DNA. What happens to the HTH belonging to the other two
subunits (B and C)? We cannot answer this question, at this point,
with much certainty. However, this mode of binding would also
bring theHTHmotif from subunit B close to the interveningminor
groove (in the N6 region) and may allow interactions between its
HTHmotif and the DNA through the minor groove. Such -helix–
DNA interactions through the minor groove, although known (40,
42), have not hitherto been observed for helices belonging to HTH
motifs. However, the existence of such interactions, involving DNA
in the region between the repeat sequences, may explain the
differences in the affinities of CII for the operator sequences at pE,
pI, and paQ (A.B.D. and P.P., unpublished results). The possibility
of such additional interactions is also suggested by the behavior of
analogous proteins from other lambdoid phages. CII protein from
 or P21 and C1 from P22 is each highly specific for its own pE
promoter (46).
It may also be noted that the model of the CII–DNA complex,
Fig. 3. The sequence of CII (2–80, observed in the structure), with the various
structural elements and interface residues highlighted. Mutations that affect
oligomerization and DNA-binding of CII are indicated.
Fig. 4. A model for DNA–CII interaction, showing how the tetrameric
assembly can enable recognition of a direct repeat on one face of a B-DNA
molecule. All of the HTH motifs are colored blue. The HTH motifs of subunits
A and D are located in the major groove of DNA. The HTH from the B subunit
may interact with DNA at the minor groove from the same face.
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although it explains the phenotypic character of all of the CII
mutants, does not explain the striking result obtained with one of
its homologous proteins, P22 C1. For this protein, it was shown that
a single base change in the N6 region of the promoter (osi
mutation), which also overlapped with the protein coding sequence
and led to Thr-6 being changed to Ala, resulted in an altered
specificity. Whereas the wild-type protein could activate transcrip-
tion from both the wild-type and the mutant promoter (albeit with
some difference in the expression level), the mutant protein could
activate only the mutant promoter (47), suggesting a possible
interaction between the DNA and the N-terminal region of C1.
However, for  CII, we do not find any possible direct interaction
between this region from any of the monomers and the promoter
DNA. Although the exact reason for this anomaly cannot be
ascertained, it seems reasonable to comment that these two pro-
teins, despite their homology, do not interact in the same manner
with their respective cognate DNA sites. Such a difference in their
modes of interaction has also been suggested (47). The other
possibility is that the N-terminal region, although not being impor-
tant for DNA binding, per se, affects a subsequent step in tran-
scription activation, which requires the formation of a ternary
complex involving DNA, the activator protein, and the RNA
polymerase.
Promoter Activation. An interesting feature of activation by CII is
that all its cognate promoters are intrinsically weak, having poor
10 and 35 sequences, and depend on CII binding for their
transcription. In fact,mutations that result in a strong10 sequence
can make the pE promoter a constitutive one, able to function
without CII (48). Effective regulation of these promoters perhaps
necessitates that they be weak and function only upon the binding
of CII. The CII-binding site flanks the35 region, where the 4 of
RNA polymerase also binds (49). Is it then possible that CII helps
the binding of RNApolymerase at the35 region? It is known that
CII and RNA polymerase can simultaneously bind to this part of
DNA, at opposite faces (2). The C-terminal domain of the -sub-
unit of RNA polymerase (CTD) contacts DNA immediately
upstreamof the35 region of pE, on the opposite face ofDNAwith
respect to CII (50). CTD is required for the CII-dependent
activation of pE (51, 52) and for lysogenization (53). Interactions
between CTD and DNA (or between CTD and ) have been
found to be critical for activation of the pE, pI, and paQ promoters
by CII, and the possibility of CII– interactions has been suggested
(54). Synergistic binding of CII and RNA polymerase to DNA has
been observed (2, 55); kinetic assays have also shown that CII
affects kinetic parameters for RNA polymerase–promoter inter-
actions (56). In the DNA-bound state, CII would be in the
immediate vicinity of both the  (49) and the  subunits (2, 57) of
RNA polymerase. All of these considerations strongly suggest
contacts between CII and RNA polymerase, although direct evi-
dence for such contacts is not available. Such a ternary CII–DNA–
polymerase complex may account for the effective activation at the
weakCII-dependent promoters and allow for its control at different
levels. Residues from the B and C subunits of CII (Fig. 4) may be
involved in such contacts to stabilize the ternary complex.
We thank Prof. Amos Oppenheim for discussions and Dr. Gautam Basu
for critical comments on the manuscript. Diffraction data were collected
at synchrotron sources at the Deutsches Elektronen Synchrotron and at
SPring-8 (Hyogo, Japan). We thank the Department of Science and
Technology (India) for supporting travel. This work was supported, in
part, by Council of Scientific and Industrial Research (India) Grant
37107101-EMR-II (to P.P.) and a fellowship (to A.B.D.). A.B.D.’s stay
in Hamburg was supported by a United Nations Educational, Scientific
and Cultural Organization–International Council for Science–Third
World Academy of Sciences fellowship.
1. Herskowitz, I. & Hagen, D. (1980) Annu. Rev. Genet. 14, 399–445.
2. Ho, Y.-S., Wulff, D. & Rosenberg, M. (1983) Nature 304, 703–708.
3. Pabo, C. O. & Sauer, R. T. (1992) Annu. Rev. Biochem. 61, 1053–1095.
4. Echols, H. (1986) Trends Genet. 2, 26–30.
5. Ptashne, M. (1992) A Genetic Switch (Cell Press, Blackwell Scientific, Cambridge,
MA), 2nd Ed.
6. Wulff, D. L., Beher, M., Izumi, S., Beck, J., Mahoney, M., Shimatake, H., Brady, C.,
Court, D. & Rosenberg, M. (1980) J. Mol. Biol. 138, 209–230.
7. Wulff, D. L., Mahoney, M., Shatzman, A. & Rosenberg, M. (1984) Proc. Natl. Acad.
Sci. USA 81, 555–559.
8. Brennan, R. G. & Matthews, B. W. (1989) J. Biol. Chem. 264, 1903–1906.
9. Datta, A. B., Chakrabarti, P., Subramanya, H. S. & Parrack, P. (2001) Biochem.
Biophys. Res. Commun. 288, 997–1000.
10. Ho, Y.-S., Lewis, M. & Rosenberg, M. (1982) J. Biol. Chem. 257, 9128–9134.
11. Datta, A. B., Roy, S. & Parrack, P. (2005) J. Mol. Biol. 345, 315–324.
12. Ramakrishnan, V., Finch, J. T., Graziano, V., Lee, P. L. & Sweet, R. M. (1993)Nature
362, 219–223.
13. Otwinowski, Z. & Minor, W. (1997) Methods Enzymol. 276, 307–326.
14. Schneider, T. R. & Sheldrick, G. M. (2002) Acta Crystallogr. D 58, 1772–1779.
15. Cowtan, K. D. & Main, P. (1998) Acta Crystallogr. D 54, 487–493.
16. Collaborative Computational Project Number 4 (1994) Acta Crystallogr. D 50,
760–763.
17. Terwilliger, T. C. (2002) Acta Crystallogr. D 58, 1937–1940.
18. Bru¨nger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-
Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998)
Acta Crystallogr. D 54, 905–921.
19. Japan Synchrotron Radiation Research Institute (2002) SPring-8 User Experiment
Report No. 9 (Japan SynchrotronRadiation Research Institute, Hyogo, Japan), p. 192.
20. Datta, A. B., Roy, S. & Parrack, P. (2003) Eur. J. Biochem. 270, 4439–4446.
21. Kobiler, O., Koby, S., Teff, D., Court, D. &Oppenheim, A. B. (2002) Proc. Natl. Acad.
Sci. USA 99, 14964–14969.
22. Banuett, F., Hoyt, M. A., McFarlane, L., Echols, H. & Herskowitz, I. (1986) J. Mol.
Biol. 187, 213–224.
23. Harrison, S. C. (1991) Nature 353, 715–719.
24. Ho, Y.-S., Mahoney, M. E., Wulff, D. L. & Rosenberg, M. (1988) Genes Dev. 2,
184–195.
25. Wintjens, R. & Rooman, M. (1996) J. Mol. Biol. 262, 294–313.
26. Holm, L. & Sander, C. (1993) J. Mol. Biol. 233, 123–138.
27. Campos, A., Zhang, R., Alkire, R. W., Matsumura, P. & Westbrook, E. M. (2001)
Mol. Microbiol. 39, 567–580.
28. Wang, J., Smerdon, S. J., Ja¨ger, J., Kohlstaedt, L. A., Rice, P. A., Friedman, J. M. &
Steitz, T. A. (1994) Proc. Natl. Acad. Sci. USA 91, 7242–7246.
29. Weber, I. T. & Steitz, T. A. (1987) J. Mol. Biol. 198, 311–326.
30. Muraoka, S., Okumura, R., Ogawa, N., Nonaka, T., Miyashita, K. & Senda, T. (2003)
J. Mol. Biol. 328, 555–566.
31. Goodsell, D. S. & Olson, A. J. (2000) Annu. Rev. Biophys. Biomol. Struct. 29, 105–153.
32. Steitz, T. A., Fletterick, R. J., Anderson, W. F. & Anderson, C. M. (1976) J. Mol. Biol.
104, 197–222.
33. Bahadur, R. P., Chakrabarti, P., Rodier, F. & Janin, J. (2003) Proteins 53, 708–719.
34. Hubbard, S. (1992) NACCESS: A Program for Calculating Accessibilities (Univ. Coll.
of London, London).
35. Lee, B. & Richards, F. M. (1971) J. Mol. Biol. 55, 379–400.
36. Jones, S. & Thornton, J. M. (1996) Proc. Natl. Acad. Sci. USA 93, 13–20.
37. Bahadur, R. P., Chakrabarti, P., Rodier, F. & Janin, J. (2004) J. Mol. Biol. 336,
943–955.
38. Harris, N. L., Presnell, S. R. & Cohen, F. E. (1994) J. Mol. Biol. 236, 1356–1368.
39. Clore, G. M., Omichinski, J. G., Sakaguchi, K., Zambrano, N., Sakamoto, H.,
Appella, E. & Gronenborn, A. M. (1994) Science 265, 386–391.
40. Lewis, M., Chang, G., Horton, N. C., Kercher, M. A., Pace, H. C., Schumacher, M. A.,
Brennan, R. G. & Lu, P. (1996) Science 271, 1247–1254.
41. Brenowitz, M., Mandal, N., Pickar, A., Jamison, E. & Adhya, S. (1991) J. Biol. Chem.
266, 1281–1288.
42. Schumacher, M. A., Choi, K. Y., Zalkin, H. & Brennan, R. G. (1994) Science 266,
763–770.
43. Shih, M.-C. & Gussin, G. N. (1984) Proc. Natl. Acad. Sci. USA 81, 6432–6436.
44. Backhaus, H. & Petri, J. B. (1984) Gene 32, 289–303.
45. Poteete, A. R., Hehir, K. & Sauer, R. T. (1986) Biochemistry 25, 251–256.
46. Wulff, D. L. & Mahoney, M. E. (1987) Genetics 115, 597–604.
47. Retallack, D. M., Johnson, L. L., Ziegler, S. F., Strauch, M. A. & Friedman, D. I.
(1993) Proc. Natl. Acad. Sci. USA 90, 9562–9565.
48. Keilty, S. & Rosenberg, M. (1987) J. Biol. Chem. 262, 6389–6395.
49. Dove, S. L., Darst, S. A. & Hochschild, A. (2003) Mol. Microbiol. 48, 863–874.
50. Kedzierska, B., Lee, D. J., Wegrzyn, G., Busby, S. J. W. & Thomas, M. S. (2004)
Nucleic Acids Res. 32, 834–841.
51. Gussin, G. N., Olson, C., Igarashi, K. & Ishihama, A. (1992) J. Bacteriol. 174,
5156–5160.
52. Obuchowski, M., Giladi, H., Koby, S., Szalewska-Palsz, A., Wegrzyn, A., Oppenheim,
A. B., Thomas, M. S. & Wegrzyn, G. (1997) Mol. Gen. Genet. 254, 304–311.
53. Wegrzyn, G., Glass, R. E. & Thomas, M. S. (1992) Gene 122, 1–7.
54. Marr, M. T., Roberts, J. W., Brown, S. E., Klee, M. & Gussin, G. N. (2004) Nucleic
Acids Res. 32, 1083–1090.
55. Shimatake, H. & Rosenberg, M. (1981) Nature 292, 128–132.
56. Shih, M.-C. & Gussin, G. N. (1984) J. Mol. Biol. 172, 489–506.
57. Campbell, E. A., Muzzin, O., Chlenov, M., Sun, J. L., Olson, C. A., Weinman, O.,
Trester-Zedlitz, M. L. & Darst, S. A. (2002) Mol. Cell 9, 527–539.
58. Weiss, M. S. (2001) J. Appl. Crystallogr. 34, 130–135.
Datta et al. PNAS  August 9, 2005  vol. 102  no. 32  11247
BI
O
CH
EM
IS
TR
Y
